1. LOW GRADE B‐CELL NON‐HODGKIN LYMPHOMAS INVOLVING THE CENTRAL NERVOUS SYSTEM: AN ANALYSIS FROM THE NATIONAL CANCER DATABASE. (June 2017) Authors: Pophali, P.A.; Thanarajasingam, G.; Pulido, J.; Johnston, P.; Go, R. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P775: CLINICAL OUTCOMES AND SOCIOECONOMIC FACTORS IN CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE UNITED STATES USING THE NATIONAL CANCER DATABASE: 2004-2017. (23rd June 2022) Authors: Mclaughlin, N.; Ruan, G.; Wudhikarn, K.; Al-Kali, A.; Tefferi, A.; Gangat, N.; Go, R.; Patnaik, M.; Shah, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 670 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P884: POTENTIAL BENEFIT OF POST-TRANSPLANT DOXYCYCLINE IN AL ACHIEVING HEMATOLOGICAL RESPONSE AFTER AUTOLOGOUS STEM CELL TRANSPLANT – LONG TERM FOLLOW UP. (23rd June 2022) Authors: Abdallah, N.; Dispenzieri, A.; Muchtar, E.; Buadi, F.; Kapoor, P.; Lacy, M.; Hwa, Y.; Fonder, A.; Hobbs, M.; Hayman, S.; Leung, N.; Dingli, D.; Go, R.; Lin, Y.; Gonsalves, W.; Binder, M.; Kourelis, T.; Warsame, R.; Kyle, R.; Rajkumar, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE. (23rd June 2022) Authors: Vaxman, I.; Kumar, S.; buadi, F.; Lacy, M.; Dingli, D.; Fonder, A.; Hobbs, M.; Hayman, S.; hwa, L. Y.; Kouralis, T.; Warsame, R.; Muchtar, E.; Nelson, L.; Kapoor, P.; Grogan, M.; Go, R.; Gonsalves, W.; Siddiqi, M.; Robert, K.; Rajkumar, V. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1552: A PHASE 2, OPEN-LABEL STUDY TO ASSESS SAFETY, TOLERABILITY, AND CLINICAL EFFECT OF ANX005 IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA AND EVIDENCE OF COMPLEMENT ACTIVATION. (23rd June 2022) Authors: Jaeger, U.; Broome, C.; Go, R.; Patriarca, A.; Roeth, A.; Chang, Q.; Weedin, N.; Adams, P.; Cahir-McFarland, E.; Kroon, H.-A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P1139: A POPULATION-BASED STUDY OF ISOLATED ADULT PULMONARY LANGERHANS CELL HISTIOCYTOSIS IN THE UNITED STATES: 2010-2017. (23rd June 2022) Authors: Ruan, G.; Abeykoon, J.; Hazim, A.; Ravindran, A.; Rech, K.; Young, J.; Cox, C.; Ryu, J.; Koster, M.; Tobin, O.; Shah, M.; Bennani, N.; Vassallo, R.; Goyal, G.; Go, R. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P08-11 Fenhexamid promoted the initial step of metastasis in MCF-7 breast cancer cells via estrogen receptor and phosphoinositide 3-kinase pathway. (1st September 2022) Authors: Nam, M.; Go, R.; Choi, K. Journal: Toxicology letters Issue: Volume 368(2022) Page Start: S145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗